IN BRIEF: MGC Pharmaceuticals sees record sales in March
IN BRIEF: MGC Pharmaceuticals sees record sales in March Tue, 27th Apr 2021 10:57 MGC Pharmaceuticals Ltd - EU-based medicinal cannabis company dual-listed in Perth and London - Reports solid sales revenue in the first quarter following its London IPO in February. Says March delivered the best monthly sales revenue for the company to date from its pharmaceutical-grade phytomedicine products. "This was thanks to sales of the phytocannabinoid product line in Australia driving its best monthly unit sales to date with almost 1,500 units sold," says MGC. Notes start to research program into the us...